×
About 24,678 results

ALLMedicine™ Tachycardia Center

Research & Reviews  8,056 results

Pediatric AML patients with acute-onset cardiomyopathy in the setting of Streptococcus ...
https://doi.org/10.1002/pbc.29450
Pediatric Blood & Cancer; Sabet K, Panigrahi A et. al.

Dec 3rd, 2021 - We reviewed three very similar cases of acute-onset heart failure in children with acute myeloid leukemia who received anthracyclines during their treatment. All three children were diagnosed with recent Streptococcus viridans bacteremia and had p...

Using Simulation to Improve Adherence to Get With the Guidelines Time to First Shock.
https://doi.org/10.4037/ccn2021596
Critical Care Nurse; Paddock A

Dec 2nd, 2021 - Evidence demonstrates that shocking patients in ventricular fibrillation or pulseless ventricular tachycardia in 2 minutes or less leads to improved outcomes. At our facility in Orlando, Florida, 4 of 7 time to first shock fallouts occurred in the...

Substrate Characterization and Outcome of Catheter Ablation of Ventricular Tachycardia ...
https://doi.org/10.1161/CIRCEP.121.010279
Circulation. Arrhythmia and Electrophysiology; Liuba I, Muser D et. al.

Dec 2nd, 2021 - The substrate for ventricular tachycardia (VT) in left ventricular (LV) nonischemic cardiomyopathy may be epicardial. We assessed the prevalence, location, endocardial electrograms, and VT ablation outcomes in LV nonischemic cardiomyopathy with is...

Autonomic dysfunction in idiopathic hypersomnia: an overlooked association and potentia...
https://doi.org/10.5664/jcsm.9818
Journal of Clinical Sleep Medicine : JCSM : Official Publ... Adra N, Reddy M et. al.

Dec 2nd, 2021 - There is a small yet robust body of literature regarding autonomic dysfunction in Idiopathic hypersomnia (IH) as well as sleep disturbances in Postural Orthostatic Tachycardia Syndrome (POTS). This review aims at summarizing the current literature...

see more →

Guidelines  11 results

Minimally Invasive Bilateral Stellate Ganglionectomy for Refractory Ventricular Tachyca...
https://doi.org/10.1016/j.jacep.2020.12.001
JACC. Clinical Electrophysiology; Elliott IA, DeJesus M et. al.

Jan 10th, 2021 - Cardiac sympathetic denervation (CSD) for refractory ventricular tachycardia (VT) has been shown to decrease VT recurrence and defibrillator shocks in patients with ischemic and nonischemic cardiomyopathy. Here and in the accompanying Video, we de...

2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement o...
https://doi.org/10.1016/j.cjca.2020.04.004
The Canadian Journal of Cardiology; Deyell MW, AbdelWahab A et. al.

Jun 17th, 2020 - This Canadian Cardiovascular Society position statement is focused on the management of sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) that occurs in patients with structural heart disease (SHD), including previous myocar...

Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia ...
https://doi.org/10.1016/j.cjca.2019.12.024
The Canadian Journal of Cardiology; Raj SR, Guzman JC et. al.

Mar 9th, 2020 - The current definition of postural orthostatic tachycardia syndrome (POTS) dates back to a small case series of patients with a subacute illness who presented with excessive orthostatic tachycardia and orthostatic intolerance, in the absence of an...

2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324904
Circulation Panchal AR, Berg KM et. al.

Dec 21st, 2018 - Antiarrhythmic medications are commonly administered during and immediately after a ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest. However, it is unclear whether these medications improve patient outcomes. This 2018 Ame...

European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythm...
https://doi.org/10.1016/j.resuscitation.2018.11.018
Resuscitation Soar J, Perkins GD et. al.

Nov 30th, 2018 - This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular ...

see more →

Drugs  567 results see all →

Clinicaltrials.gov  322 results

Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS)
https://clinicaltrials.gov/ct2/show/NCT00962728

Nov 22nd, 2021 - Chronic orthostatic intolerance, sometimes known as the postural tachycardia syndrome (POTS), is the most common disorder among patients seen at several centers specializing in diseases of the autonomic nervous system. It affects an estimated 500,...

Use of SVS Device to Improve Outcomes for Neonatal Opioid Withdrawal Syndrome.
https://clinicaltrials.gov/ct2/show/NCT04834297

Nov 19th, 2021 - In preliminary work using a research grade device, the investigators tested stochastic vibrotactile stimulation (SVS) in infants with NOWS. Twenty six full term infants who were opioid exposed, as determined by meconium drug screening tests and/or...

Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury
https://clinicaltrials.gov/ct2/show/NCT02783105

Nov 17th, 2021 - Paroxysmal sympathetic hyperactivity (PSH) is a frequent symptom after traumatic brain injury and concerns up to 30% of severely brain-injured patients. PSH is due to unbalanced autonomic nervous system activity, resulting in sympathetic surges ca...

Wearable Then Implantable Cardiac Defibrillator After Myocardial Infarction
https://clinicaltrials.gov/ct2/show/NCT05123885

Nov 17th, 2021 - Sudden death from ventricular arrhythmia is a serious and common complication of myocardial infarction, especially with low left ventricular ejection fraction (LVEF). Implantable cardiac defibrillator (ICD) implantation is currently recommended at...

Physical Training in Patients With POTS After Covid-19
https://clinicaltrials.gov/ct2/show/NCT05094622

Nov 10th, 2021 - Introduction: Covid-19 was declared a global pandemic in March 2020 by the World Health Organization (WHO). In August 2021, there are over 1 100 000 confirmed cases and over 14 000 deaths in Sweden. Initially, it was suspected that Covid-19 would ...

see more →

News  884 results

No advantage shown for LAA ligation as adjunct to pulmonary vein isolation
https://www.mdedge.com/cardiology/article/248647/arrhythmias-ep/no-advantage-shown-laa-ligation-adjunct-pulmonary-vein
Ted Bosworth

Nov 15th, 2021 - In patients treated for persistent atrial fibrillation (AFib) with pulmonary vein antral isolation (PVAI), there was a numerical but not a statistical advantage for adjunctive left atrial appendage (LAA) ligation in a multicenter randomized trial.

No Advantage Shown for LAA Ligation as Adjunct to Pulmonary Vein Isolation
https://www.medscape.com/viewarticle/962954

Nov 15th, 2021 - In patients treated for persistent atrial fibrillation (AFib) with pulmonary vein antral isolation (PVAI), there was a numerical but not a statistical advantage for adjunctive left atrial appendage (LAA) ligation in a multicenter randomized trial....

CRAVE: No Spike in Atrial Arrhythmias Among Coffee Drinkers
https://www.medscape.com/viewarticle/962909

Nov 14th, 2021 - A novel trial using real-time monitoring found that drinking coffee did not increase atrial arrhythmias but was associated with more premature ventricular contractions. There was no increase in premature atrial contractions (PACs) or supraventricu...

Rosuvastatin-Induced Rhabdomyolysis, Pancreatitis, Transaminitis, and Acute Kidney Injury
https://www.mdedge.com/fedprac/article/248530/diabetes/rosuvastatin-induced-rhabdomyolysis-pancreatitis-transaminitis-and
Brent Wagner, MD, MS, G. Patricia Escobar, DVM et. al.

Nov 10th, 2021 - Attention should be paid to changing a tolerated medication to another within its class. Many drugs approved by the US Food and Drug Administration (FDA), have equivalent therapeutic properties as existing drugs.

Strategies for Managing Atrial Fibrillation in Patients on BTKi
https://www.onclive.com/view/strategies-for-managing-atrial-fibrillation-in-patients-on-btki

Oct 15th, 2021 - Farrukh Awan, MD: Atrial fibrillation [AFib] is the most common issue with these patients [with chronic lymphocytic leukemia]. Another thing I learned the hard way is that when patients without a history of AFib got on a BTK inhibitor, with a rapi...

see more →

Patient Education  31 results see all →